Devea is a French company established in 2009, dedicated to providing innovative solutions for biodecontamination and Airborne Surface Disinfection (ASD) in the pharmaceutical industry. With a team that boasts a unique expertise in centrifugation technology as well as bioburden management, Devea addresses the stringent requirements for disinfection in sensitive environments. The company holds the distinction of being the only French ASD entity to possess a Marketing Authorisation (FR-2019-0071) across most European countries, underscoring the efficacy of its solutions.

Services include:
– Finished Dosage Forms
– Biodecontamination solutions
– Airborne Surface Disinfection (ASD)
– Specialized disinfection strategies for high-requirement rooms

Devea continues to lead the way in advanced disinfection technologies, ensuring optimal environments for the pharmaceutical industry. For further information, please visit devea-environnement.com.